CN118234716A - 艾地苯醌衍生物及其在治疗植物中的用途 - Google Patents

艾地苯醌衍生物及其在治疗植物中的用途 Download PDF

Info

Publication number
CN118234716A
CN118234716A CN202280075238.3A CN202280075238A CN118234716A CN 118234716 A CN118234716 A CN 118234716A CN 202280075238 A CN202280075238 A CN 202280075238A CN 118234716 A CN118234716 A CN 118234716A
Authority
CN
China
Prior art keywords
compound
group
alkyl
groups
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280075238.3A
Other languages
English (en)
Chinese (zh)
Inventor
马修·怀特曼
罗伯塔·托雷格罗萨
马克·伍德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitox Therapy Ltd
Original Assignee
Mitox Therapy Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitox Therapy Ltd filed Critical Mitox Therapy Ltd
Publication of CN118234716A publication Critical patent/CN118234716A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/38—Amides of thiocarboxylic acids
    • C07C327/48—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CN202280075238.3A 2021-09-14 2022-09-14 艾地苯醌衍生物及其在治疗植物中的用途 Pending CN118234716A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2113117.2 2021-09-14
GB2113117.2A GB2610815A (en) 2021-09-14 2021-09-14 Compounds
PCT/GB2022/052325 WO2023041906A1 (en) 2021-09-14 2022-09-14 Idebenone derivatives and their use in treating plants

Publications (1)

Publication Number Publication Date
CN118234716A true CN118234716A (zh) 2024-06-21

Family

ID=78149340

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280075238.3A Pending CN118234716A (zh) 2021-09-14 2022-09-14 艾地苯醌衍生物及其在治疗植物中的用途

Country Status (10)

Country Link
US (1) US20240400536A1 (enExample)
EP (1) EP4396174A1 (enExample)
JP (1) JP2024535017A (enExample)
KR (1) KR20240108380A (enExample)
CN (1) CN118234716A (enExample)
AU (1) AU2022347098A1 (enExample)
CA (1) CA3231394A1 (enExample)
GB (1) GB2610815A (enExample)
MX (1) MX2024003214A (enExample)
WO (1) WO2023041906A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025104452A1 (en) 2023-11-17 2025-05-22 Mitorx Therapeutics Ltd Compounds for use in treatment

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1154112B (de) * 1961-04-21 1963-09-12 Bayer Ag Verfahren zur Herstellung von Mercaptomethylnaphthochinonderivaten
AU2004266988B2 (en) * 2003-08-22 2011-05-26 Antipodean Pharmaceuticals, Inc. Mitoquinone derivatives used as mitochondrially targeted antioxidants
WO2009111576A2 (en) * 2008-03-05 2009-09-11 Edison Pharmaceuticals, Inc. 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES
US8263094B2 (en) 2008-09-23 2012-09-11 Eastman Chemical Company Esters of 4,5-disubstituted-oxy-2-methyl-3,6-dioxo-cyclohexa-1,4-dienyl alkyl acids and preparation thereof
JP2016515526A (ja) * 2013-03-15 2016-05-30 エジソン ファーマシューティカルズ， インコーポレイテッド 酸化ストレス障害の処置のためのアルキル−ヘテロアリール置換されたキノン誘導体
CN107226789B (zh) * 2017-05-09 2019-11-08 北京大学 氨基二硫代甲酸酯类化合物、其制备方法以及在制备抗肿瘤药物中的用途
CN110950749B (zh) * 2018-09-26 2023-07-25 中国科学院广州生物医药与健康研究院 Ido抑制剂及其制备方法和应用

Also Published As

Publication number Publication date
KR20240108380A (ko) 2024-07-09
JP2024535017A (ja) 2024-09-26
GB2610815A (en) 2023-03-22
MX2024003214A (es) 2024-07-30
CA3231394A1 (en) 2023-03-23
WO2023041906A1 (en) 2023-03-23
US20240400536A1 (en) 2024-12-05
AU2022347098A1 (en) 2024-04-04
GB202113117D0 (en) 2021-10-27
EP4396174A1 (en) 2024-07-10

Similar Documents

Publication Publication Date Title
EP3083603B1 (de) Benzimidazolderivate als ep4-liganden
EP3838900B1 (en) 3-aryloxy-3-aryl-propylamine compound and uses thereof
RU2694899C9 (ru) Производные пиридинкарбоксамида, способ их получения и их фармацевтическое применение
CZ20032696A3 (cs) Thiohydantoiny a jejich použití při léčení cukrovky
JP6725530B2 (ja) 軸方向キラル異性体及びその製造方法と製薬用途
ES3057371T3 (en) Antagonists of the muscarinic acetylcholine receptor m4
WO2012022121A1 (zh) 作为盐皮质激素受体拮抗剂的并环类化合物
US6395730B1 (en) Potassium channel inhibitors
KR20060099513A (ko) 무스카린 수용체의 조정자로서의 페닐-피페라진 유도체
KR102836866B1 (ko) 포스포디에스테라제 저해제의 용도
KR100227953B1 (ko) 신규한 3,4-디하이드로이소퀴놀린 유도체, 및 카보사이클 및 헤테로사이클 융합된 디하이드로피리딘 및 이들을 함유하는 약제학적 제제
JPWO2007043568A1 (ja) Ｓ１ｐ３受容体拮抗剤
DE60205265T2 (de) 1-glyoxylamidindolizine zur behandlung von krebs
TW202033520A (zh) 用作fgfr4抑制劑的稠環衍生物
AU2005266493B2 (en) Inhibitors of Hsp90
CN118791418A (zh) 一种吲哚类化合物及其制备方法与应用
EP3259256B1 (en) Compounds and methods for inducing browning of white adipose tissue
KR20240108380A (ko) 이데베논 유도체 및 식물의 치료에서의 그의 용도
CA3138238A1 (en) Method for treating endometriosis-associated pain by using diaminopyrimidine compound
CN113272315A (zh) 一类类固醇化合物及其用途
CN117126134A (zh) 新型四氢异喹啉类化合物、其制备方法、包含此类化合物的药物组合物及其用途
US6174908B1 (en) Potassium channel inhibitors
CN107304199B (zh) 一种新的喜巴辛类似物及其在医药中的应用
RU2491284C2 (ru) Адренергические соединения
KR900007244B1 (ko) 신규 피페리도 벤즈 이미다졸 유도체

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination